<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography (SPECT) with <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> challenge has increasingly been used for evaluating hemodynamic reserve in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>The accuracy of this test, however, has not been validated with <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) </plain></SENT>
<SENT sid="2" pm="."><plain>In 14 patients who had occlusive disease of the internal carotid artery or the trunk of the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) with minimal or no infarction on computed tomography (CT) and magnetic resonance imaging (MRI), we compared <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> reactivity on SPECT with N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi>-p-[123I]-iodoamphetamine to hemodynamic parameters determined with gas inhalation labeled <z:chebi fb="2" ids="36932">15O</z:chebi> steady-state PET studies </plain></SENT>
<SENT sid="3" pm="."><plain>The asymmetry index (AI)--i.e., the percentage of the activity rate of the ischemic <z:chebi fb="70" ids="34342">MCA</z:chebi> territory versus the contralateral one, was determined by SPECT </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="27690">Acetazolamide</z:chebi> reactivity expressed as delta AI, or change in AI after <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> challenge, was significantly lower in seven patients than -8.4%, the lower limit of the 95% confidence interval for the <z:mpath ids='MPATH_458'>normal</z:mpath> reactivity </plain></SENT>
<SENT sid="5" pm="."><plain>Values of ipsilateral CBF, cerebral blood volume (CBV)/CBF, and oxygen extraction fraction (OEF) and contralateral OEF were significantly different between patients with <z:mpath ids='MPATH_458'>normal</z:mpath> and reduced <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> reactivity </plain></SENT>
<SENT sid="6" pm="."><plain>Values of delta AI were correlated with OEF (r = -0.87; p &lt; 0.001) and CBV/CBF (r = -0.56; p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with OEF &gt; 0.52, the mean + 2 SD calculated from five <z:mpath ids='MPATH_458'>normal</z:mpath> volunteers, also had reduced <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> reactivity, while the patients with <z:mpath ids='MPATH_458'>normal</z:mpath> OEF values had <z:mpath ids='MPATH_458'>normal</z:mpath> reactivity </plain></SENT>
<SENT sid="8" pm="."><plain>The present study has demonstrated that SPECT studies with an <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> challenge can detect the Stage II hemodynamic failure </plain></SENT>
</text></document>